Latest News

12345678910
As Nvidia Launches New AI Laptop Chips, Should You Buy NVDA Stock?
Nvidia is expanding into AI-powered laptops as record data center growth and bullish analyst targets keep NVDA stock in focus.
Via Barchart.com · February 25, 2026
Penumbra (NYSE:PEN) Reports Bullish Q4 CY2025
Medical device company Penumbra (NYSE:PEN) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 22.1% year on year to $385.4 million. Its non-GAAP profit of $1.18 per share was 6.1% above analysts’ consensus estimates.
Via StockStory · February 25, 2026
Cava's Yearly Revenue Just Topped $1 Billion for the First Time and Its Stock Is Up 20%. Is the Restaurant Stock a Buy?fool.com
Is the stock ready for another breakout?
Via The Motley Fool · February 25, 2026
Telus: Buy, Sell, or Hold in 2026?https://www.fool.ca/2026/02/25/telus-buy-sell-or-hold-in-2026-2/?source=iedfctemc0000001&utm_source=financialcontent&utm_campaign=CA_All_Articles&utm_content=Articles&utm_medium=rssfeed&lidx=0&referring_guid=a01618e7-ea7d-4341-a8bb-9cc04fac38b6
Let's dive into the bull and bear thesis for a company like Telus (TSX:T) and where this stock may be headed over the medium to long term.
Via The Motley Fool · February 25, 2026
Intel Stock Surges 90% In A Year — Can The Rally Last?talkmarkets.com
Via Talk Markets · February 25, 2026
Software Apocalypse Or AI Hallucination?talkmarkets.com
Via Talk Markets · February 25, 2026
Buy the Dip, or Buy the Rip? Is It Too Late to Invest in the Stock Market?https://www.fool.ca/2026/02/25/buy-the-dip-or-buy-the-rip-is-it-too-late-to-invest-in-the-stock-market/?source=iedfctemc0000001&utm_source=financialcontent&utm_campaign=CA_All_Articles&utm_content=Articles&utm_medium=rssfeed&lidx=0&referring_guid=ea58a109-ac09-4adf-81bb-94f9249c1b40
Let's dive into the age-old question of whether buying into a stock market at all time highs makes sense, or if investors should be more cautious.
Via The Motley Fool · February 25, 2026
Structure Therapeutics Stock Soars Over 200% as One Fund Adds to a $242 Million Positionfool.com
Structure Therapeutics develops oral drugs for chronic diseases, with lead assets targeting diabetes, obesity, and cardiovascular care.
Via The Motley Fool · February 25, 2026
Amazon Is Now the No. 1 Company in the World by Revenue. Does That Make AMZN Stock a Buy Here?
Becoming the world’s top revenue generator strengthens Amazon’s story, yet heavy AI capex keeps valuation risks in focus.
Via Barchart.com · February 25, 2026
Piano Movers in JVC: Expert Relocation Services for Your Instrument and Moretalkmarkets.com
Via Talk Markets · February 25, 2026
Here's How Much $1000 Invested In Strategy 15 Years Ago Would Be Worth Todaybenzinga.com
Via Benzinga · February 25, 2026
4 Things Retail Investors Need to Know About President Trump's Latest Tariff Movesfool.com
The new 15% "global" tariff replaces the discontinued "Liberation Day" tariffs.
Via The Motley Fool · February 25, 2026
Robinhood (HOOD) Stock Trades Up, Here Is Why
Shares of financial services company Robinhood (NASDAQ:HOOD) jumped 5.9% in the afternoon session after a rally in Bitcoin renewed expectations for increased trading activity on its platform. 
Via StockStory · February 25, 2026
Strategy (MSTR) Stock Trades Up, Here Is Why
Shares of bitcoin development company Strategy (NASDAQ:MSTR) jumped 9% in the afternoon session after a rally in the price of Bitcoin created upward pressure on the heavily shorted stock. 
Via StockStory · February 25, 2026
Why Is MarineMax (HZO) Stock Soaring Today
Shares of boat and marine products retailer MarineMax (NYSE:HZO) jumped 8.8% in the afternoon session after reports surfaced that more potential buyers, including private equity firms Blackstone and Centerbridge Partners, expressed interest in acquiring the company. 
Via StockStory · February 25, 2026
Jazz Pharmaceuticals (JAZZ) Stock Trades Up, Here Is Why
Shares of biopharma company Jazz Pharmaceuticals (NASDAQ:JAZZ) jumped 13.5% in the afternoon session after the company reported better-than-expected fourth-quarter 2025 revenue and earnings. 
Via StockStory · February 25, 2026
Why Flywire (FLYW) Stock Is Up Today
Shares of global payments company Flywire (NASDAQ:FLYW) jumped 10.1% in the afternoon session after it reported fourth-quarter 2025 results that beat Wall Street's expectations for both revenue and earnings. Revenue grew 39.7% year-over-year to $157.5 million, surpassing analyst estimates by 9.3%. The company also posted a GAAP earnings per share of $0.00, which was an upside surprise to analysts who had forecast a loss of $0.01 per share. In addition, adjusted EBITDA of $25.4 million came in nearly 10% ahead of consensus. Overall, the significant top- and bottom-line beats drove the positive investor sentiment.
Via StockStory · February 25, 2026
Target Hospitality (TH) Shares Skyrocket, What You Need To Know
Shares of workforce housing company Target Hospitality (NASDAQ:TH) jumped 6.5% in the afternoon session after it announced a second 400-bed expansion to a workforce community supporting data center development, significantly increasing its capacity and future revenue. 
Via StockStory · February 25, 2026
Why Super Micro (SMCI) Stock Is Trading Up Today
Shares of server solutions provider Super Micro (NASDAQ:SMCI) jumped 8% in the afternoon session after the company made two significant announcements: a successful test of its AI infrastructure as a high-speed 'Virtual Power Plant' and the launch of a new enterprise AI data platform. 
Via StockStory · February 25, 2026
Why Are Pure Storage (PSTG) Shares Soaring Today
Shares of data storage solutions provider Pure Storage (NYSE:PSTG) jumped 9.6% in the afternoon session after the company announced a major rebranding to 'Everpure' and its intent to acquire data intelligence firm 1touch, signaling a strategic shift ahead of its earnings report. 
Via StockStory · February 25, 2026
Evolent Health (EVH) Shares Skyrocket, What You Need To Know
Shares of healthcare solutions company Evolent Health (NYSE:EVH) jumped 20.7% in the afternoon session after the company reported fourth-quarter earnings that beat expectations and provided an optimistic revenue forecast for the upcoming year. 
Via StockStory · February 25, 2026
Why Resideo (REZI) Stock Is Trading Up Today
Shares of home automation and security solutions provider Resideo Technologies (NYSE:REZI) jumped 13.5% in the afternoon session after the company reported fourth-quarter revenue that topped Wall Street estimates and provided an upbeat financial outlook for 2026. Resideo's sales in the fourth quarter rose 2% year-on-year to $1.90 billion, edging past analysts' expectations. However, the company's adjusted earnings of $0.50 per share fell short of consensus estimates by 4.5%. Investors appeared to focus on the company's strong forecast. For the upcoming first quarter, Resideo guided for revenue of $1.88 billion at the midpoint, which was 4.6% higher than what analysts had anticipated. Furthermore, its full-year 2026 guidance was a highlight, with projections for adjusted earnings per share and EBITDA beating consensus estimates by 11% and 5% respectively. The optimistic outlook suggests management expects robust performance ahead, outweighing the mixed results of the past quarter.
Via StockStory · February 25, 2026
What Is One of the Best Tech Stocks to Hold for the Next Decade?fool.com
The advent of artificial intelligence is about to be bottlenecked in a big way most investors have yet to notice.
Via The Motley Fool · February 25, 2026
Protagonist Stock Up 120%, but One Fund Just Revealed a $170 Million Exitfool.com
This biotech innovator develops peptide-based therapies for blood and immune disorders, advancing a pipeline of clinical-stage candidates.
Via The Motley Fool · February 25, 2026
Cava Stock Jumps Into Overbought Territory. Is It Too Late to Buy CAVA Now?
CAVA stock soared on strong Q4 earnings that triggered a technical breakout. Here’s why Stifel sees CAVA shares pushing even higher through the remainder of 2026.
Via Barchart.com · February 25, 2026
Palantir Billionaire Peter Thiel Dumped Nvidia, Tesla, Microsoft, and Apple. What Stocks Does He Own for 2026?fool.com
His latest SEC filing reveals that the venture capitalist's hedge fund sold its entire stock portfolio last quarter.
Via The Motley Fool · February 25, 2026
SYM, TSLA Stocks Rise On Reports Of Upcoming Govt. Meeting To Discuss Robotics Policiesstocktwits.com
Semafor reported on Wednesday that the upcoming roundtable is aimed at bolstering the domestic robot industry as U.S. competition with China intensifies.
Via Stocktwits · February 25, 2026
A 2.7% Dividend Stock Paying Cash Every Monthhttps://www.fool.ca/2026/02/25/a-2-7-dividend-stock-paying-cash-every-month/?source=iedfctemc0000001&utm_source=financialcontent&utm_campaign=CA_All_Articles&utm_content=Articles&utm_medium=rssfeed&lidx=0&referring_guid=430480ea-938b-4315-adee-554731092cfb
Valued at a market cap of $5.7 billion, EIF is a TSX dividend stock that remains a top pick in 2026.
Via The Motley Fool · February 25, 2026
Vail Resorts Heads Into Ski Season Backed by Strong Epic Pass Salesfool.com
BAMCO trimmed its position in Vail Resorts as Epic Pass sales set up the winter season. Vail runs a large portfolio of destination resorts, and investors will be watching whether traffic and guest spending will support the company's earnings outlook.
Via The Motley Fool · February 25, 2026
Is Lumen Technologies Stock a Buy or Sell After a Director Dumped 45,000 Shares?fool.com
This U.S. telecom and technology provider reported a notable insider sale amid a year of significant share price movement.
Via The Motley Fool · February 25, 2026
Disc Medicine Stock Is Swinging, but This Fund's New $52 Million Bet Shows Convictionfool.com
Disc Medicine develops therapies for rare blood disorders, leveraging clinical-stage biotech expertise in red blood cell biology.
Via The Motley Fool · February 25, 2026
Prediction: The Quantum Computing Hype Could Cool Off in 2026 -- Here's Whyfool.com
Don't rush to buy the dip on these popular quantum computing stocks.
Via The Motley Fool · February 25, 2026
Dollar Falls as Stocks Rally
The dollar index (DXY00 ) on Wednesday fell by -0.16%. The dollar moved lower on Wednesday amid a stronger yuan, which rallied to a 2.75-year high. Also, comments on Tuesday evening by President Trump at the State of the Union address fueled trade...
Via Barchart.com · February 25, 2026
An Ideal TFSA Stock With a 2.2% Payout Each Monthhttps://www.fool.ca/2026/02/25/an-ideal-tfsa-stock-with-a-2-2-payout-each-month/?source=iedfctemc0000001&utm_source=financialcontent&utm_campaign=CA_All_Articles&utm_content=Articles&utm_medium=rssfeed&lidx=0&referring_guid=4017a096-aed4-40bd-b1ff-74c06c14a0eb
This under-the-radar Canadian stock pays a monthly dividend and is quietly building a compelling growth story.
Via The Motley Fool · February 25, 2026
Ready, Set, Invest: How Canadians Can Get Ready Now to Prosper All Yearhttps://www.fool.ca/2026/02/25/ready-set-invest-how-canadians-can-get-ready-now-to-prosper-all-year/?source=iedfctemc0000001&utm_source=financialcontent&utm_campaign=CA_All_Articles&utm_content=Articles&utm_medium=rssfeed&lidx=0&referring_guid=9ed3044f-b773-47fc-92bc-ee40af8447ed
Here are a couple of key strategies Canadian investors can employ to prosper as we kick off what could be another volatile year in the stock market.
Via The Motley Fool · February 25, 2026
Apogee Therapeutics Stock Up 100% as Fund Lifts Stake to $28 Millionfool.com
This biotech specializes in monoclonal antibody therapies for inflammatory and immunological diseases with significant unmet needs.
Via The Motley Fool · February 25, 2026
The Dirty Little Secrets That Sank Ford's Q4fool.com
There were a couple of unusual factors weighing on Ford's fourth-quarter results. Here's what investors need to know.
Via The Motley Fool · February 25, 2026
First Solar Shares Rise 3% After Key Trading Signalbenzinga.com
A key trading signal flashed for First Solar shares at a price of $208.35, after which FSLR rose 3% to an intraday high.
Via Benzinga · February 25, 2026
Here's Why Broadcom Stock Is a Buy Before March 4fool.com
Broadcom is one of the most balanced AI stocks to buy in 2026.
Via The Motley Fool · February 25, 2026
This Fund Bet $20 Million on RAPT Therapeutics as Stock Surges 500% This Past Year and Buyout Offer Emergesfool.com
RAPT Therapeutics develops oral therapies for oncology and inflammatory diseases, with lead candidates progressing in clinical trials.
Via The Motley Fool · February 25, 2026
Cracking the Chip Monopoly: Meta Invests in AMD Chipsmarketbeat.com
Via MarketBeat · February 25, 2026
Axon Stock Is Challenging Its 50-Day Moving Average. Should You Buy AXON on the Post-Earnings Rally?
Axon shares soar on a strong Q4 release and impressive future guidance. RBC Capital Markets continues to see significant further upside in AXON stock.
Via Barchart.com · February 25, 2026
Crude Oil Prices Pressured by a Surge in Weekly EIA Inventories
April WTI crude oil (CLJ26 ) on Wednesday closed down -0.21 (-0.32%), and April RBOB gasoline (RBJ26 ) is up +0.0152 (+0.68%). Crude oil and gasoline prices gave up an early advance on Wednesday and settled mixed. Wednesday's bearish EIA inventory r...
Via Barchart.com · February 25, 2026
Nat-Gas Prices Recover on Risks of Cold US March Temps
March Nymex natural gas (NGH26 ) on Wednesday closed up by +0.054 (+1.85%). March nat-gas prices recovered from a 4.25-month nearest-futures low on Wednesday and settled higher. Short-covering emerged in nat-gas futures on Wednesday after longer-te...
Via Barchart.com · February 25, 2026
Netflix’s Co-CEO Ted Sarandos To Reportedly Visit White House To Discuss Warner Bros. Deal As Paramount’s Bid Gains Momentumstocktwits.com
Netflix is under significant pressure from Paramount Skydance to acquire Warner Bros., particularly following Paramount’s recent $31-per-share offer and scrutiny from DOJ’s antitrust division.
Via Stocktwits · February 25, 2026
Sun Communities (SUI) Q4 2025 Earnings Transcriptsun-com
Sun Communities (SUI) Q4 2025 Earnings Transcript
Via The Motley Fool · February 25, 2026
Disc Medicine Lands New $20 Million Investment as FDA Sets Up Potential Q4 Catalystfool.com
This clinical-stage biotech develops therapies targeting hematologic disorders, with a pipeline centered on red blood cell biology.
Via The Motley Fool · February 25, 2026
CoreWeave Q4 Preview: Gerstner's New Stock Pick Goes For Third Straight Double Beat — 'Really Interesting Opportunity'benzinga.com
CoreWeave reports Q4 results Thursday. Here's the key items to watch with shares up 25% year-to-date in 2026.
Via Benzinga · February 25, 2026
What's Behind The Rise In Fiserv Stock?benzinga.com
Fiserv shares are trading higher Wednesday. The company partnered with Peoples Group to develop Canada's next-gen payments platform.
Via Benzinga · February 25, 2026
DME Capital Scooped Up Over 2 Million Capri Holdings Shares. Is the Stock a Buy?fool.com
Capri Holdings is a global luxury group behind Versace, Jimmy Choo, and Michael Kors, serving premium markets across multiple continents.
Via The Motley Fool · February 25, 2026